ArticleCancer management and research2021

Lenvatinib Plus Camrelizumab versus Lenvatinib Monotherapy as Post-Progression Treatment for Advanced Hepatocellular Carcinoma: A Short-Term Prognostic Study.

Fuqun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.